Unlocking the Power of Influenza Vaccines for Pediatric Population: A Narrative Review

TL;DR

This review summarizes how influenza vaccines work in children, focusing on their safety, immune response, and effectiveness in preventing flu-related complications.

Contribution

The paper provides a comprehensive narrative review of influenza vaccine performance in children, emphasizing safety and effectiveness.

Findings

Influenza vaccines induce strong immune responses in children through neutralizing antibodies.

Live attenuated vaccines show higher effectiveness against matched strains compared to inactivated vaccines.

Influenza vaccines are generally safe in children, with mild and temporary side effects.

Abstract

The flu, often known as influenza, is a dangerous public health hazard for the pediatric population. Immunization is essential for decreasing the burden of the disease and avoiding complications related to influenza. However, the immunogenicity, efficacy, and safety of different influenza vaccines in children warrant careful evaluation.

The purpose of this narrative review is to give a summary of the existing literature on the immunogenicity, efficacy, and safety of several vaccinations against influenza viruses in children. The review incorporates evidence from a range of studies focusing on the outcomes of interest. Immunogenicity studies have shown that influenza vaccines induce a robust immune response in children, primarily through neutralizing antibodies’ formation. However, variations in vaccine composition influence the duration and magnitude of immune responses. Safety is a crucial consideration in pediatric vaccination. In children, influenza vaccinations have generally shown a high safety profile, with mild and temporary side effects being the most common. Vaccinations against influenza have shown a modest level of efficacy in avoiding hospitalizations linked to influenza, laboratory-confirmed influenza infections, and serious consequences in children. Live attenuated vaccines have shown higher effectiveness against matched strains compared to inactivated vaccines. In conclusion, this narrative review highlights that receiving influenza vaccination in children aged six to 47 months is very important. While different vaccines exhibit varying immunogenicity, safety profiles, and effectiveness, they all contribute to reducing the burden of influenza among children. Future research should focus on optimizing vaccine strategies, improving vaccine coverage, and evaluating long-term protection.